Ingalls & Snyder’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.18M Buy
7,817
+255
+3% +$97.3K 0.08% 138
2026
Q2
$3.01M Buy
7,562
+331
+5% +$145K 0.08% 144
2026
Q1
$3.33M Buy
7,231
+248
+4% +$125K 0.12% 120
2025
Q4
$3.96M Buy
6,983
+50
+0.7% +$26.6K 0.15% 111
2025
Q3
$3.1M Buy
6,933
+960
+16% +$461K 0.1% 129
2025
Q2
$3.25M Buy
5,973
+503
+9% +$263K 0.12% 122
2025
Q1
$2.71M Buy
5,470
+708
+15% +$392K 0.09% 131
2024
Q4
$2.49M Sell
4,762
-273
-5% -$142K 0.1% 128
2024
Q3
$2.47M Buy
5,035
+700
+16% +$326K 0.1% 135
2024
Q2
$1.93M Buy
4,335
+582
+16% +$232K 0.08% 144
2024
Q1
$1.5M Buy
+3,753
New +$1.42M 0.07% 174

Other funds holding ISRG

Ingalls & Snyder's ISRG Position: Q3 2026 in Review

Ingalls & Snyder increased its Intuitive Surgical (ISRG) stake by 3.4% in Q3 2026, buying an estimated $97.3K and bringing the position to 7,817 shares worth $3.18M. The position accounts for 0.08% of the portfolio, ranked #138.

Ingalls & Snyder first reported a position in ISRG in Q1 2024 and has held it in 11 quarters since. The position peaked at $3.96M in Q4 2025. 1,919 funds tracked by Wall St. Rank hold ISRG as of Q3 2026.

  • Ingalls & Snyder held 7,817 shares of Intuitive Surgical worth $3.18M as of Q3 2026.
  • Ingalls & Snyder bought 255 Intuitive Surgical shares in Q3 2026, an estimated $97.3K.
  • Intuitive Surgical made up 0.08% of Ingalls & Snyder's portfolio in Q3 2026, its #138 holding.
  • Ingalls & Snyder first reported a position in Intuitive Surgical in Q1 2024 and has held it in 11 quarters since.
  • Ingalls & Snyder's Intuitive Surgical position peaked at $3.96M in Q4 2025.
  • 1,919 funds tracked by Wall St. Rank held Intuitive Surgical as of Q3 2026.

Based on Ingalls & Snyder's 13F filing for Q3 2026, filed 12 Nov 2026.